Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Beijing Tong Ren Tang Chinese Medicine Co ( (HK:3613) ).
Beijing Tong Ren Tang Chinese Medicine Co. has issued a supplemental notice for its upcoming annual general meeting on June 3, 2025. The notice includes additional resolutions for the re-election of Mr. Yue Zheng and Mr. Yan Han as executive directors. Shareholders are advised to submit a revised form of proxy to accommodate these new resolutions, ensuring their voting rights are maintained at the meeting.
More about Beijing Tong Ren Tang Chinese Medicine Co
Beijing Tong Ren Tang Chinese Medicine Co. is a company incorporated in Hong Kong, operating within the traditional Chinese medicine industry. The company focuses on the production and distribution of Chinese medicinal products and services, catering to a market with a strong emphasis on traditional health practices.
Average Trading Volume: 1,499,065
Technical Sentiment Signal: Sell
Current Market Cap: HK$7.2B
See more insights into 3613 stock on TipRanks’ Stock Analysis page.

